Dáil Éireann Debate, Tuesday - 7 November 2023
1364. Deputy Colm Burke asked the Minister for Health the status of Pembrolizumab, used in the treatment of triple negative breast cancer (details supplied); and if he will make a statement on the matter. [48793/23]
Amharc ar fhreagraUnder the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for decisions on the pricing and reimbursement of medicines; therefore, the matter has been referred to the HSE for attention and direct reply to the Deputy.
